InsiderTrades

Form 4 for WHWK Whitehawk Therapeutics, Inc.

Accepted 2026-03-10 00:00:00 ET · period of report 2026-03-01 · accession 0001995275-26-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-03-10 2026-03-01 WHWK Lennon David James CEO, Dir M - OptEx — +16.2K 49.7K +49% —
D 2026-03-10 2026-03-02 WHWK Lennon David James CEO, Dir S - Sale+OE $3.31 -5,100 44.6K -10% -$16.9K
D 2026-03-10 2026-03-01 WHWK Lennon David James CEO, Dir M - OptEx $0.00 -16.2K 32.5K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-01 M A 16,250 — 49,679 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock.
2 Common Common Stock 2026-03-02 S D 5,100 $3.31 44,579 D — —
3 Derivative Restricted Stock Units 2026-03-01 M D 16,250 $0.00 32,500 D — · — to — 16,250 Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock. (F3) Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024.